ID: ALA4783319

Max Phase: Preclinical

Molecular Formula: C34H37N5O6

Molecular Weight: 611.70

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ccccc1C(=O)OC(C)OC(=O)OC1CCCCC1

Standard InChI:  InChI=1S/C34H37N5O6/c1-3-11-31(40)39(22-24-18-20-25(21-19-24)27-14-7-8-15-28(27)32-35-37-38-36-32)30-17-10-9-16-29(30)33(41)43-23(2)44-34(42)45-26-12-5-4-6-13-26/h7-10,14-21,23,26H,3-6,11-13,22H2,1-2H3,(H,35,36,37,38)

Standard InChI Key:  ZMDLYWFWFXKUGG-UHFFFAOYSA-N

Associated Targets(Human)

NEDD8-activating enzyme E1 regulatory subunit 121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 611.70Molecular Weight (Monoisotopic): 611.2744AlogP: 6.86#Rotatable Bonds: 11
Polar Surface Area: 136.60Molecular Species: ACIDHBA: 9HBD: 1
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.23CX Basic pKa: CX LogP: 7.39CX LogD: 5.78
Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.14Np Likeness Score: -0.83

References

1. Chen X,Yang X,Mao F,Wei J,Xu Y,Li B,Zhu J,Ni S,Jia L,Li J.  (2021)  Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth invitro and invivo.,  210  [PMID:33129593] [10.1016/j.ejmech.2020.112964]

Source